Monday, November 21, 2011

Security Stocks; United Protection Security Group Inc. (TSX-V: UZZ) - Q3 - RESULTS

EDMONTON - November 21, 2011 (InvestorIdeas.com Newswire) - F.V.Ramsoondar, Chief Executive Officer of United Protection Security Group Inc. ("UPSG" or the "Company"), (TSX-V:UZZ) is pleased to announce that the Company has released its Q3- 2011 results.
F.V.Ramsoondar states: "The quarter ended September 30, 2011 continued to reflect the results of the restructuring and cost management that was initiated earlier in the year. My focus will be to continue to build profitability back into the Company, which will enable my team to deliver on our growth strategies.
Investorideas.com Newswire (1) EBIITDA = Earnings before interest, impairment, taxes, depreciation and amortization
(2) EBIITDAS = Earnings before interest, impairment, taxes, depreciation and amortization and share-base payments.
Pursuant to a press release dated October 24, 2011, the Company is in the process of closing a new receivable financing facility of $4.5 USD million dollars, which does not impose any financial covenants. The Company's current receivable financing facility is capped at $3 million CAD and imposes a financial covenant that is currently in breach. Mr. Ramsoondar has executed a personal guarantee for the new facility and will be issued 8 million common shares of the Company at $0.05 per share as compensation. This $400,000 non-cash cost will be reflected in the Company's Q4-2011 results. The new facility will enable the Company to finance its organic growth plans effectively.
Revenue
Revenue was $8,758,376 for the third quarter 2011 compared to $8,496,968 for the comparative period, an increase of $261,408 or 3.08%. The increase in revenue is primarily related to sales and marketing efforts the Company deployed over the last two financial quarters.
Gross margin
Gross margin was $1,635,321 (18.67%) for the third quarter 2011 compared to $1,463,313 (17.22%) for the comparative period. The increase in gross margin is attributed to controlling overtime costs and managing other operational costs effectively.
Operating costs
Operating costs remain consistent at $7,123,055 for the third quarter 2011 compared to $7,033,655 for the quarter 2010.
Selling and administrative expenses ("S&A")
S&A totalled $1,233,212 for the third quarter 2011 compared to third quarter 2010 at $1,407,511, reflecting a decrease of $174,299 or 12.38%, the direct impact of the management cost-restructuring plan implemented in May 2011.
Stock Awareness Activities
To find out more about United Protection Security Group Inc. (TSX-V: UZZ), visit our website at www.unitedprotection.com. To join the 'request for information', go to the web page www.unitedprotection.com and click the tab 'request information' and follow the prompts.
Statements in this press release other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, are forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in the Company's business, including risks related to business development and retention, and risks related to the current economic and credit conditions. These risks are discussed in the Company's Management Discussion and Analysis and other continuous disclosure documents. As a result, actual results may vary materially from those described in the forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For additional investor and media relations inquiries contact:
Fredy Ramsoondar CEO and Director
Email: fredy.ramsoondar@unitedprotection.com
Tel: 780-465-8101
Disclosure: UZZ is a paid advertising client on Investorideas.com and our defense portals.
Visit the UZZ showcase profile at Investorideas.com
Request News and Info on UZZ
Biotech and Pharma stocks News; BioSante Pharmaceuticals (NASDAQ: BPAX) Added to NASDAQ Biotechnology Index

LINCOLNSHIRE, Ill. - November 21, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), today announced that it has been added to the NASDAQ Biotechnology Index� (Symbol: NBI), effective prior to the stock market open today, November 21, 2011.
The NASDAQ Biotechnology Index is designed to track the performance of a set of NASDAQ-listed securities that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The NASDAQ Biotechnology Index is a modified market capitalization-weighted index, and the index securities are evaluated semi-annually in May and November.
"We are delighted that BioSante has been added to the NASDAQ Biotechnology Index, as it recognizes our established role in the biotechnology industry, adds greater visibility for our company and could lead to a broader stockholder base,� stated Phillip Donenberg, BioSante�s senior vice president of finance and chief financial officer.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD), which is in Phase III clinical development according to a U.S. Food and Drug Administration (FDA) Special Protocol Assessment (SPA). BioSante's first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante's licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other BioSante products are Bio-T-Gel™, a testosterone gel for male hypogonadism, for which an NDA is pending, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development. Additional information is available online at: www.biosantepharma.com.
Contact:
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
Harris D. McKinney, Inc.
Alan Zachary
312-506-5220
azachary@harrisdmckinney.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
Request news, updates and trading alerts on BPAX and other showcase stocks http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp  
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp  
Source: Investorideas.com, BioSante, Investorideas.com
800 665 0411 cvanzant@investorideas.com

Friday, November 18, 2011

Thursday's NASDAQ Gainers: RMBS, ZOLL, VIAS, AMCN

POINT ROBERTS - November 18, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Thursday November 17th. Nasdaq ended with a loss of 51.62 (-1.96%) to 2,587.99.
Rambus Inc. (NASDAQ:RMBS) was the biggest percentage gainer and bounced back $1.67 (23.49%) to $8.78 . The stock fell over 60% in the prior trading session after a California Superior Court jury announced a decision against the company.
ZOLL Medical Corporation (NASDAQ:ZOLL) added $8.18 (22.94%) to close at $43.84 after the company said that it earned 52 cents a share on revenue of $151.9 million, compared to a year ago profit of 33 cents a share on revenue of $120.4 million. The company projects to see 17 to 19 percent revenue growth in 2012.
Viasystems Group, Inc. (NASDAQ:VIAS) gained $3.27 (21.96%) to $18.16 after the company withdrew plans to offer 4 million shares to the public. ViaSystems, which had announced the offering last week, said there is too much volatility in the market right now, and that the company's stock is undervalued.
AirMedia Group Inc. (ADR) (NASDAQ:AMCN) climbed 0.40 (17.02%) to $2.75, rebounding from its recent fall. Airmedia Group Inc. is a holding company, which conduct operations through its subsidiaries, consolidated variable interest entities and the variable interest entities' subsidiaries in the People's Republic of China.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
00-665-0411
Source - www.Investorideas.com
TSX Stocks to Watch; Thursday's Trading Leaders: (TSX: HAT), (TSX: LSG), (TSX: POT), (TSX: AVR)

November 18, 2011 - Investorideas.com, a leader in sector research for independent investors issues a trading alert for TSX trading leaders for November 17, 2011. The Standard & Poor's/TSX Composite Index slumped 258.93 (-2.13%) to close the day at 11,915.43.
Hathor Exploration Limited (TSX:HAT) was the biggest stock mover on the TSX Thursday, ending higher by 0.14 (2.87%) to C$5.01 after the company announced that Rio Tinto plc., through an indirect wholly owned Canadian subsidiary (Rio Tinto), has increased its all-cash offer to acquire all of the outstanding common shares of Hathor to $4.70 per share.
Lake Shore Gold Corp. (TSX:LSG) ended lower by 0.15 (-8.67%) to C$1.58 on over 4.28 million shares, compared to its 30-day average volume of 3.97 million shares. Earlier this week, announced the completion of an initial National Instrument ("NI") 43-101 resource estimate for the Company's wholly owned Fenn-Gib property located approximately 60 km's east of Timmins, Ontario.
Potash Corp./Saskatchewan Inc. (TSX:POT) fell 1.97 (-4.28%) to C$44.11 on over 3.83 million shares, compared to its average volume of 2.68 million shares. The stock slid as agricultural commodities slumped on Euro-zone debt fears.
Avion Gold Corporation (TSX:AVR) shares slumped 0.21 (-11.35%) to close the day at C$1.64 on over 2.91 million shares on no major news. The stock has slumped over 26% in the past three trading sessions after the company said that it profit slid 2 cents a share from 4 cents as mining and processing costs nearly doubled. Avion also trimmed its production outlook for the year to 92,000-95,000 ounces of gold from its previous view of 95,000-100,000 ounces.
About InvestorIdeas.com: Big Ideas for small cap Investors
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411

Thursday, November 17, 2011

Security and Defense Stocks; United Protection Security Group Inc. (TSX-V: UZZ) - Alarm Monitoring Appointment

EDMONTON - November 17, 2011 (InvestorIdeas.com Newswire) - F.V.Ramsoondar, Chief Executive Officer of United Protection Security Group Inc. ("UPSG" or the "Company"), (TSX-V:UZZ) is pleased to announce that the Company has appointed Mr. Ray Wilderman as Vice President of Alarm Monitoring and Intelligent Video Analytics Systems.
F. Ramsoondar states " Mr. Wilderman was an Executive Manager with VOXCOM Security Systems for over 10 years; during his tenure there, VOXCOM grew to be the fourth largest Alarm Monitoring Security Company in Canada and was independently ranked as one of the fastest growing companies in Canada, servicing over 100,000 customers. He has been involved with numerous entrepreneurial businesses, from start-ups to public offerings, and has extensive experience in recurring revenue business models and was the architect of very successful Alarm Monitoring Dealer and Acquisition Programs."
F. Ramsoondar further states "Mr. Wilderman also has an extensive background in working with the major oil and gas, telecommunications, utilities and transportation companies locally and abroad. I look forward to the growth of our Alarm Monitoring recurring revenue line with his appointment."
Stock Awareness Activities
To find out more about United Protection Security Group Inc. (TSX-V: UZZ), visit our website at www.unitedprotection.com. To join the 'request for information', go to the web page www.unitedprotection.com and click the tab 'request information' and follow the prompts.
Statements in this press release other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, are forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in the Company's business, including risks related to business development and retention, and risks related to the current economic and credit conditions. These risks are discussed in the Company's Management Discussion and Analysis and other continuous disclosure documents. As a result, actual results may vary materially from those described in the forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For additional investor and media relations inquiries contact:
Fredy Ramsoondar CEO and Director
Email: fredy.ramsoondar@unitedprotection.com
Tel: 780-465-8101
United Protection Security Group Inc. (TSX - V: UZZ)
5909 - 83rd Street, Edmonton, Alberta T6E 3Y4
Telephone (780) 465-8101
Disclosure: UZZ is a paid advertising client on Investorideas.com and our defense portals.
Visit the UZZ showcase profile at Investorideas.com
Request News and Info on UZZ
TSX Stocks to Watch; Wednesday's Trading Leaders: (TSX: LSG), (TSX: SU), (TSX: JAG), (TSX: CNQ)

November 17, 2011 - Investorideas.com, a leader in sector research for independent investors issues a trading alert for TSX trading leaders for November 16, 2011. The Standard & Poor's/TSX Composite Index ended lower by 54.91 (-0.45%) to close the day at 12,174.36, after hitting session high of 12,295.32.
Lake Shore Gold Corp. (TSX:LSG) was the most traded stock on TSX and closed with a gain of 0.11 (6.79%) to C$1.73 after the company after the gold junior announced the completion of an initial National Instrument 43-101 resource estimate for its wholly-owned Thunder Creek property near Timmins, Ontario.
Suncor Energy Inc. (TSX: SU) ended higher by 0.49 (1.52%) to C$32.75 on over 6.82 million shares, compared to its 30-day average volume of 5.75 million shares. The stock rallied as Crude oil prices climbed over 2% to close above $102 a barrel.
Jaguar Mining Inc. (TSX: JAG) gained 2.52 (46.15%) to C$7.98 and made a new 52-week high of $8.36 after the company confirmed that that it has received proposals over the past few weeks. The Board of Directors has determined to initiate a strategic process to explore alternatives to maximize shareholder value.
Canadian Natural Resources Limited (TSX: CNQ) shares jumped 1.18 (3.15%) to close the day at C$38.69 on over 4.76 million shares on no major news. Canadian Natural Resources Limited is an independent energy company engaged in the acquisition, exploration, development, production, marketing and sale of crude oil, NGLs, and natural gas production.
About InvestorIdeas.com: Big Ideas for small cap Investors
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411
Wind Stocks to Watch: (OTCBB: JUHL), (NYSE:MY), (TSX.V: CTW), (NasdaqGS: AMSC)

Point Roberts, WA - November 17, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research, releases a trading and news alert for small and large cap wind stocks, Juhl Wind Inc. (OTCBB: JUHL), China Ming Yang Wind Power Group (NYSE: MY), Catch the Wind Ltd. (TSX-V: CTW.V) and American Superconductor (NasdaqGS: AMSC).
Juhl Wind, Inc. (OTCBB: JUHL) Reports Third Quarter 2011 Financial Results, Revenue Up 276%
Nine Months Revenue Increases over 245% from 2010, Company Holds Over $6 Million in Cash
Juhl, the Leader in Community Wind Power, reported Tuesday its results for the third quarter of 2011. Revenue for the third quarter 2011 was $3,259,000 compared to $867,000 in the third quarter of 2010, or an increase of 276%. In addition, for the nine months ended September 30, 2011 , the Company posted a record $10.9 million in revenue and $2.4 million in net income. Juhl Wind also reported continued growth in its cash position due to development fees, ending the first nine months of 2011 with approximately $6 million in cash.
Juhl Wind's stock closed up 5% at $0.63 in Wednesday's trading session following Tuesday's news.
American Superconductor (NasdaqGS: AMSC) was featured in commentary today, "5 Small Stocks With Home-Run Potential "at TheStreet. The stock is trading at $4.28, up 0.24 (5.94%) 12:15PM EST.
China Ming Yang Wind Power Group (NYSE: MY ), a leading wind turbine manufacturer in China , today announced that it has signed a strategic cooperation agreement with Guangdong Yudean Group Co., Ltd. ("Yudean") to foster off-shore wind power development in Guangdong province and to localize the production of multi-megawatt wind turbine generators ("WTG"). Yudean is the largest power generation company in Guangdong province.
According to the strategic cooperation agreement, Ming Yang will supply its 3MW, 5MW and 6MW Super Compact Drive ("SCD") WTGs to Yudean's off-shore wind power technology demonstration project in Xuwen, Zhanjiang. The demonstration project is expected to have a total power output of 200MW, and is located on the eastern coastal areas of Xinliao Island, Xuwen, Zhanjiang. Testing and evaluation for the off-shore wind resources and site selection have already been conducted.
Catch the Wind Ltd. (TSX-V: CTW.V), providers of laser-based wind sensor products and technology, announced yesterday that it will hold a conference call to discuss its third quarter results for 2011 on Tuesday, November 29, 2011 at 10:00 a.m. ET. In compliance with disclosure requirements for TSX Venture Exchange issuers, the Company will report its financial results on November 28, 2011 after market close. The stock is trading up 24% today on light volume.
About Investorideas.com a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks on Facebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure : Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com.
Disclosure : Investorideas.com was compensated fifteen hundred dollars for the dissemination and publishing of this news online and via email by third party IR firm
Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com is not compensated by BCOn
For more information about Investorideas.com contact:
800.665.0411
Infrastructure/ Construction Stock News: Fireman's Contractors (OTCBB:FRCN) First Quarter Revenues Increases 109% over Fiscal Year First Quarter 2011

DALLAS and FORT WORTH, Texas - November 17, 2011 - Fireman's Contractors Inc. (OTCBB: FRCN) (OTCQB:FRCN.OB) and its board of directors are proud to announce that it had a increase of first quarter revenues of 109% from fiscal year first quarter revenue of 2011. The 2012 First quarter was July 1, 2011 through September 30, 2011 . The gross revenue is in addition to the 290% increase that the Company had in fiscal 2011, July 1, 2010 thru June 30, 2011.
Renee Gilmore , CEO of Fireman's Contractors, stated, "Continuing efforts to cultivate relationships with our commercial clients was the ultimate reason for our continued growth. This is an exciting time for Fireman's Contractors as we continue to increase our staff and professional representatives; we look forward to continuous future growth."
Recently Fireman's Contractors announced that it launched its Franchise Development Program after finalizing its Federal Disclosure Document required by the Federal Trade Commission. The Franchise Development Program aims to expand market share through franchise expansion. The Franchise Development Program is being lead by a team of highly successful experienced franchise development professionals that has successfully facilitated well over 7,000 franchises sales in their 300 cumulative years of franchise industry experience during the course of their careers.
For More Information about FRCN Please Visit: http://www.FiremansContractors.com
About the Fireman's Contractors:
FIREMAN'S CONTRACTORS Inc. (OTCBB: FRCN) is a full service contractor providing professional services for commercial and government clients. Services include Road Improvements, Pavement Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, and ADA Compliance. Fireman's Contractors has completed its FDD requirements with the Federal Trade Commission and has developed franchise territories across the U.S. The Company's goal is to develop hundreds of new franchise locations in the next 24 to 48 months. Fireman's Contractors brings a professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations.
Founded by a Firefighter, Fireman's Contractors - Contractors You Can Trust (R)
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement.
Contact:
Fireman's Contractors Inc.
2406 Gravel Road
Fort Worth , TX 76118
Phone: 800-475-1479
info@FiremansContractors.com
http://www.Firemans-Contractors.com
Investor Relations Contact:John Pentony, IR Affiliates
Contact: john@iraffiliates.com
Tel: 469.252.3031
Public Relations Contact: Danielle O'Neal
Contact: PR@FiremansContractors.com
Tel: 800-475-1479
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Twitter.com
http://twitter.com/#!/firemansco

Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Facebook.com
http://www.facebook.com/FiremansContractors


Fireman's Contractors Inc. (OTCBB:FRCN), (OTCQB:FRCN.OB) is a featured construction stock on Investorideas.com
Visit the company profile to learn more: http://www.investorideas.com/CO/FRCN/
Disclaimer/ Disclosure: FRCN has compensated Investorideas.com ten thousand for three months of advertising. All info published is sourced from public files or the Company. This is not a solicitation go buy or sell securities.
Mining and Silver Investor Trading Alert: SilverCrest Mines (TSX-V: SVL, OTCQX: STVZF) Trades up over 12% on 2,536,522 Shares

November 17, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors issues a trading alert and news update for mining investors following SilverCrest Mines (TSX-V: SVL, OTCQX: STVZF) . The stock had a record volume trading session Wednesday closing up at $2.06, up 0.23 (12.57%) on 2,536,522 shares.
The stock has gained momentum and increased share price following Monday's news "
SilverCrest Mines (TSX-V: SVL, OTCQX: STVZF) Identifies Large Bulk Tonnage Target at La Joya; Hole 17 intercepts 205.2m Grading 92.7 gpt Silver Equivalent"
More about Silvercrest Mines (TSX-V: SVL, OTCQX: STVZF): videos , analyst commentary:
http://www.theaureport.com/pub/co/292
To view accompanying maps for the news release visit : http://media3.marketwire.com/docs/fourMaps.pdf
Investorideas.com Newswire News:
SilverCrest Mines Inc. announced Monday, that data compilation for the Phase I drilling program and a newly received historic database has identified a large, near-surface bulk tonnage target at its La Joya property in Durango, Mexico. The compilation by SilverCrest has involved data and/or drill core review of 51 historic holes (14,786 metres) and 26 Company drill holes (5,716 metres) totaling 20,502 metres of drilling in 77 holes on the property. Verification or validation work completed by an Independent Qualified Person included review of 22 historic holes, Company drill information, geologic mapping, sampling, geochemistry, and historic airborne and ground geophysics. The compilation of these data will be incorporated into the upcoming NI43-101 Technical Report and resource estimate.
All 26 SilverCrest drill holes and 27 historic drill holes (verified with assays) intersected polymetallic mineralization that includes silver (Ag), copper (Cu), gold (Au), lead (Pb), zinc (Zn), tungsten (W) and molybdenum (Mo). Thirty three widely-spaced holes approximately 100 metres apart have identified a large, near-surface bulk tonnage target in the Phase I drilling area along the Main Mineralized Trend ("MMT") at La Joya.The MMT is defined, by using results from the Company's Phase I program and validated historic drill hole information, as a semi-continuous Ag-Cu-Au-Pb-Zn mineralized corridor with current "drilled-defined" dimensions of approximately 1,000 metres by 500 metres. The MMT includes a combination of wide vertical stockwork zones and multiple-stacked, polymetallic, stratabound horizons up to 230 metres in vertical thickness with grades ranging from 15.9 gpt to 202.4 gpt Ag equivalent*.
The remaining 44 holes that lie outside the Phase I drilling area have identified extensions to current mineralization along the MMT (see news release dated October 17, 2011) and have discovered a number of additional separate targets. Information from the historic database has extended the "overall" dimensions of the Main Mineralized Trend to greater than 2.5 kilometres in strike length by approximately one kilometre in width (see table on next page, attached maps and sections).
Full News release :http://www.investorideas.com/news/2011/mining/11142.asp
Contact:
SilverCrest Mines Inc.
Fred Cooper
(604) 694-1730 ext. 108 or Toll Free: 1-866-691-1730
(604) 694-1761 (FAX)
info@silvercrestmines.com
www.silvercrestmines.com
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. Silvercrest Mines has compensated Investorideas.com for the dissemination and publishing of its news through Investorideas.com site and subscribers and its partner sites and IR firm for a two week program, for three thousand per week
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com
Wednesday's NASDAQ Top Percentage Gainers: CEDC, MU, TSRA, RJET

POINT ROBERTS - November 17, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Wednesday November 16th. NASDAQ ended lower by 46.59 (-1.73%) to 2639.61.
Central European Distribution Corp (NASDAQ:CEDC) was the biggest percentage gainer and ended with a gains of 0.74 (24.18%) to $3.80 rebounding from its recent falls. The stock recently made a new 52-week low of $2.75.
Micron Technology, Inc. (NASDAQ:MU) gained 1.28 (23.44%) to $6.74 after A California Superior Court jury announced its decision in favor of the company related to a price-fixing case filed by the chip design company Ramous (NASDAQ:RMBS) against the company and Hynix Semiconductor. Shares of Rambus got crushed, plunging 60.59% to $7.11, posting a new multiyear low at $4.00.
Tessera Technologies, Inc. (NASDAQ:TSRA) gained 2.95 (20.39%) to $17.42 on very unusual volume of 4.07 million shares, compared to its average volume of 419K shares. Samsung Electronics Co., Ltd. exercised the renewal option in its Jan. 1, 2005 license agreement with Tessera, Inc. to extend the term of that license to May 17, 2017.
Republic Airways Holdings Inc. (NASDAQ:RJET) also climbed 0.54 (13.17%) to $4.64 after the company announced that it has signed an OnPointSM Fuel & Carbon Solutions agreement with GE Aviation. Under this agreement, GE’s Fuel & Carbon Solutions team will use decision software and fuel consulting and work with Republic Airways to identify and track operational improvements that could reduce the airline’s fuel spend by an average of 3%.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com
Cleantech Stock Alert: Juhl Wind (OTCBB: JUHL) Trades Up on News of 276% Increase in Third Quarter Revenue

Point Roberts, WA - November 17, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research, releases a trading and news alert for wind stock, Juhl Wind Inc. (OTCBB: JUHL).
As oil prices top the $100 barrel mark once again , investors that follow renewable energy stocks are looking for the winners within the sector. Following some major disappointments in solar stocks and the headlines of the Solyndra failure, a wind stock that is growing in revenue, net income and cash is gaining investor attention .
Juhl Wind's stock closed up 5% at $0.63 in Wednesday's trading session following Tuesday's news.
Juhl Wind, Inc. Reports Third Quarter 2011 Financial Results, Revenue Up 276%
Nine Months Revenue Increases over 245% from 2010, Company Holds Over $6 Million in Cash
Juhl Wind Inc. (OTCBB: JUHL), the Leader in Community Wind Power, reported Tuesday its results for the third quarter of 2011. Revenue for the third quarter 2011 was $3,259,000 compared to $867,000 in the third quarter of 2010, or an increase of 276%. In addition, for the nine months ended September 30, 2011 , the Company posted a record $10.9 million in revenue and $2.4 million in net income. Juhl Wind also reported continued growth in its cash position due to development fees, ending the first nine months of 2011 with approximately $6 million in cash.
"We are very proud of our results through the third quarter of 2011 as we continue a historic year for our company," stated Dan Juhl , Chairman and CEO of Juhl Wind Inc. "Our financial results are a direct result of our work on six major wind projects during a very difficult time in our economy - which we believe is direct evidence of Juhl Wind 's leading position in the energy industry. These projects include Adams , Danielson, Grant County , Valley View, Winona County and Woodstock Municipal. We have fully developed, managed construction and brought most of these projects into full service over the past two years and will be wrapping up work on all of them in the last quarter of this year."
"When combined with our previous experience, these projects bring our total project count to 20 wind farms - a level reached by few independent firms in this sector," added John Mitola , President of Juhl Wind . "Our performance in the face of such a difficult environment speaks for itself and we are confident that these results create a very strong base for our future growth."
Results for the nine-month period ended September 30, 2011:
* Revenue for the first nine months of 2011 was $10,937,000 compared to $3,170,000 for 2010, or an increase of $7,767,000 , or 245%. Revenue for the third quarter 2011 was $3,259,000 compared to $867,000 in the third quarter of 2010, or an increase of 276%. The increase in revenue for the nine months ended September 30, 2011 is primarily attributable to approximately $5.0 million of wind farm development fee revenue from three wind farm projects that completed financing arrangements during 2011 and approximately $1.7 million in revenue from the sale of our development rights in the Crofton Hills project.
* Our Operating Income of approximately $4,264,000 for the nine months ended September 30, 2011 is primarily attributable to the increased wind farm development fee revenue which provides high margin of profitability upon revenue recognition. Our operating income for the third quarter increased by approximately $1,019,000 , or 193%, from an operating loss of approximately $529,000 for the quarter ended September 30, 2010 to operating income of approximately $490,000 for the quarter ended September 30, 2011 . The increase in operating income for the quarter is primarily related to the sale of our development rights on the Crofton Hills project although we did see increases in investor relations expenses to heighten exposure of Juhl Wind 's stock and operating expenses associated with the take-over of the Woodstock wind farm during its lower wind production months.
* Our Net Income of $2,419,000 for the nine months ended September 30, 2011 represents a $4,328,000 improvement in the bottom-line from the comparative quarter a year ago. The increase in net income over the nine-month period is largely attributable to the increased revenue sources noted under revenue and operating income sections above. Our net income is impacted by inconsistent revenue patterns of our wind farm development services business as revenue recognition is significantly impacted by the timing of the completion and financing of wind farm projects.
* Basic and fully diluted earnings per share of $0.10 income per common share for the nine months ended September 30, 2011 compares to the $0.10 loss per common share for the comparative nine months ended in 2010.
* As of September 30, 2011 , the Company reported it held approximately $6.0 million in the form of cash and short term investments, which includes approximately $422,000 in balances that are restricted by a debt covenant.
A full analysis of results for the period ended September 30, 2011 is available in the Company's Form 10-Q, which is available on the Company's website at www.juhlwind.com.
About Juhl Wind Inc.
Juhl Wind is an established leader in Community Based Wind Power development and management, focused on wind farm projects throughout the United States and Canada . Juhl Wind pioneered community-based wind farms, developing the currently accepted financial, operational and legal structure providing local ownership of medium-to-large scale wind farms. To date, the Company has completed 19 wind farm projects and provides operations management and oversight across the portfolio. Juhl Wind services every aspect of wind farm development from full development and ownership, general consultation, construction management and system operations and maintenance. With its acquisition of the Woodstock Hills wind farm in April of 2011, the Company now owns and operates a 10.2 MW wind farm. Through its Next Generation Power Systems subsidiary ("NextGen'), Juhl Wind also provides full sales and service to smaller, on-site wind and solar projects in addition to our larger Community Wind Farms. Juhl Wind is based in Woodstock, Minnesota and is traded on the OTCBB under the symbol JUHL. Additional information is available at the Company's website at www.juhlwind.com or by calling 877-584-5946 (or 877-JUHLWIN).
Follow Juhl Wind , Inc. on Facebook HERE!
For more information, contact:
Juhl Wind Investor Relations
Jody Janson
Phone: (888) 438-JUHL (or 888-438-5845)
Email: jody@istockdaily.com
FORWARD LOOKING STATEMENTS
This news release includes forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 including statements that reflect Juhl Wind 's current expectations about its future results, performance, prospects and opportunities. Juhl Wind has tried to identify these forward-looking statements by using words and phrases such as "may," "will," "expects," "anticipates," "believes," "intends," "estimates," "plan," "should," "typical," "preliminary," "hope," or similar expressions. These forward-looking statements are based on information currently available to Juhl Wind and are subject to a number of risks, uncertainties and other factors that could cause Juhl Wind 's actual results, performance, prospects or opportunities in the remainder of 2011 and beyond to differ materially from those expressed in, or implied by, these forward-looking statements and specifically those statements referring to any specific projects, prospective acquisitions and wind farm assets mentioned herein. New projects are subject to large, third party risks that may not be in control of Juhl Wind including the timing of funding and actual construction. While new wind farms noted from time to time are large-scale construction projects, Juhl Wind may not be the primary contractor for the provision of certain services, as it is in certain of its other projects. These risks are referenced in Juhl Wind 's current 8K or as may be described from time to time in Juhl Wind 's subsequent SEC filings; and such factors as incorporated by reference.
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks on Facebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure : Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com.
Disclosure: Investorideas.com was compensated fifteen hundred dollars for the dissemination and publishing of this news online and via email by third party IR firm
Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com is not compensated by BCOn
For more information about Investorideas.com contact:
800.665.0411

Wednesday, November 16, 2011

Trading Alert: PositiveID (OTCBB:PSID) Trades up over 50% on FDA News

POINT ROBERTS - November 16, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors issues a trading alert for medical technology stock, PositiveID Corporation (OTCBB:PSID), following news of its FDA clearance for iglucose(TM) mobile health system for diabetes. The stock has moved up over 52% on news with volume of over two million shares in morning trading.
PositiveID Corporation (OTCBB:PSID), a developer of medical technologies for diabetes management and clinical diagnostics, announced today it has received clearance from the U.S. Food and Drug Administration ("FDA") for its iglucose(TM) mobile health system for diabetes management. iglucose uses mobile technology to revolutionize the way individuals with diabetes manage their condition. By seamlessly communicating glucose readings from data-capable glucometers to the iglucose diabetes management portal, this important data can be shared with family members, caregivers and healthcare professionals. This makes it possible to improve care in a cost-effective manner and help loved ones manage their diabetes.
iglucose is a First-of-its-Kind Wireless Communication System for Diabetes Management
PositiveID to Begin Commercialization Efforts in First Quarter 2012
Full news: http://www.investorideas.com/news/2011/main/11161.asp
Investorideas.com Newswire About PositiveID Corporation (OTCBB:PSID),
PositiveID Corporation, based in Delray Beach, Florida, is a technology development company with two divisions: HealthID and MicroFluidic Systems. HealthID develops unique medical devices, focused primarily on diabetes management, and MicroFluidic Systems develops molecular diagnostic systems, focused primarily on bio-threat detection products. For more information on PositiveID, please visit www.PositiveIDCorp.com.
For more information on iglucose, please visit www.iglucose.com.
Contact:
Allison Tomek
PositiveID Corporation
561-805-8000
atomek@positiveidcorp.com
Published at Investorideas.com Newswire
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. Investorideas.com was compensated fifteen hundred to publish and distribute PositiveID Corporation  press release by third party IR www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com
Biotech Stock Alert; Aethlon Medical (OTC: AEMD) Releases Shareholder Letter

SAN DIEGO - November 16, 2011 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD) disclosed today that its Chairman and CEO, James A. Joyce , has issued the following letter to shareholders.
To our Shareholders:
Earlier this year, we introduced and began marketing the Aethlon ADAPT™ system, a technology platform that intersects the medical device and drug world to establish a new class of therapeutics that allow for the selective subtraction of disease-enhancing particles from patient circulation without adding drug toxicity. Not long ago, the medical community consensus was that it would not be possible for a medical device to remove harmful particles from circulation without also stripping out essential elements required for health. Well, as Walt Disney once stated, "Its kind of fun to do the impossible." I would add immensely challenging as well. Therapies that evolve from our platform hold the potential to alter the healthcare industry by unlocking the ability to attack disease survival mechanisms that are beyond the reach of drugs. Today, we are advancing ADAPT-based endeavors to address unmet medical needs in cancer, infectious disease, and now sepsis.
On October 3rd , we proudly disclosed that the first sale of our Aethlon ADAPT™ system occurred when we signed a $6.8 million contract with the United States of America . The contract resulted from our response to a "Dialysis-Like Therapeutics" (DLT) program offered through the Defense Advanced Projects Agency (DARPA). DARPA is a primary engine for innovation in our country and we are honored to be working with them on a project whose mission includes saving the lives of wounded soldiers. Under the DLT program, the Aethlon ADAPT™ system will be tested as a core technology component of a therapeutic device that would prevent sepsis, a fatal bloodstream infection that is often the cause of death in combat-injured soldiers. In this application, the open architecture of our technology platform provides a therapeutic template to immobilize a combination of affinity compounds to selectively target sepsis-enabling factors in circulation.
DARPA estimates the successful development of this device would save thousands of lives and billions of dollars in the United States each year. In regards to the global opportunity, more than 18 million cases of sepsis are reported each year, with more than six million resulting in death. We have also been tasked by DARPA to advance a novel blood pump design that seamlessly integrates with therapeutic devices, yet reduces or eliminates the systemic administration of anticoagulants normally required during extracorporeal therapies.
Last week, we received our first milestone payment under the DARPA award, which officially transitioned our corporate status from development-stage to revenue stage organization. Now that we are contract proven, we plan to increase our efforts to market the Aethlon ADAPT™ system to government health and military agencies that seek innovative strategies to address life-threatening or debilitating disease conditions.
With each subsequent sale of the Aethlon ADAPT™ system, we reinforce the value of our therapeutic vision, reduce our reliance on the capital markets, and further establish a unique business model that allows us to generate revenue as we clinically advance pipeline therapies to market. Our technology platform also provides a basis to establish collaborative business relationships with biotechnology and pharmaceutical organizations that might have interest in pursuing a medical device regulatory and commercialization pathway for their affinity drug agents. As toxicity eliminates a majority of affinity drug agents from entering the market, we provide the opportunity to repurpose clinical stage affinity drugs as well as previous clinical dropouts.
On September 21st , we again leveraged the Aethlon ADAPT™ system to introduce a targeted breast cancer therapy known as HER2osome™ and enlisted clinical support from thought leaders in the cancer field. In this application, HER2osome™ provides a therapeutic strategy to maximize the ability of the immune system and established drug therapies to combat HER2+ breast cancer, which is characterized by aggressive growth and poor prognosis resulting from the over-expression of HER2 protein. Our therapeutic goal is to inhibit HER2+ breast cancer progression by reducing the circulatory presence of HER2 protein and tumor-secreted exosomes that contribute to the development and progression of breast cancer.
When we first initiated research into tumor-secreted exosomes, the consensus thought was that exosomes were nothing more than cellular garbage bags having no meaningful function. Today, exosomes have emerged to become an important new therapeutic target in cancer care, yet remain unaddressed with drug therapy. In a forthcoming disclosure, we will discuss some of our other exosome related endeavors. However, as it relates to breast cancer, research publications indicate that breast cancer exosomes suppress the immune response, stimulate angiogenesis, contribute to the spread of metastasis, and inhibit the therapeutic benefit of Herceptin®, a leading monoclonal antibody treatment against the HER2+ breast cancer. Quite simply, we are developing HER2osome™ because we believe the resulting device will enhance the benefit of Herceptin® and standard of care chemotherapies without adding drug toxicity or interaction risks. In this regard, the Aethlon ADAPT™ system provides a therapeutic template to immobilize both an anti-HER2 antibody and an exosome targeted affinity agent as a basis to simultaneously clear both targets from the circulatory system of HER2+ breast cancer patients. Like all Aethlon ADAPT™ derived therapies, HER2osome™ is designed for utilization on dialysis machines or CRRT systems already located in hospitals and clinics worldwide.
While this is certainly an exciting time for our organization, there is something else I want to address before concluding my letter. That is the treatment of Hepatitis C (HCV) infected individuals with our Hemopurifier®, which is the lead product in our ADAPT product pipeline. Our Hemopurifier® has demonstrated broad-spectrum capabilities against viral pathogens, including HCV, the human immunodeficiency virus (HIV), and a variety of tested bioterror and pandemic threats. Specific to treating HCV, we previously conducted studies that demonstrated the safe administration of our Hemopurifier® in HCV-infected dialysis patients whose average viral load reductions exceeded 50% during each four-hour treatment. These results were obtained in the absence of any drug therapy.
Our HCV treatment results led us to ask the question, what if we administered Hemopurifier® therapy to non-dialysis patients when they initiated HCV drug therapy? To find the answer, we initiated our first clinical study in non-dialysis patients at the Medanta Medicity Institute in India . We already knew that rapid viral load depletion in the first few days of therapy correlated with patients who achieve a sustained viral response, the clinical definition for cure. Confidence in our study plan was further driven by knowledge that the Japanese Ministry of Health and Welfare had approved a non-specific dual plasmapheresis configuration that was shown to improve patient outcomes when administered in the first three days of HCV drug therapy. Based on these factors, our prior treatment outcomes, and the magnitude of HCV opportunity, we believed the Medanta study would contribute to improving shareholder value. We were wrong. Study delays, including protocol changes, patient recruitment challenges, and other mishaps instead contributed to an erosion of shareholder value. That said, I want to reinforce that there has been no indication that our Hemopurifier® isn't performing in the manner we had expected.
Certain delays may prove to be beneficial. On July 19 th, we met with FDA to discuss a proposal to initiate Hemopurifier® clinical studies in the U.S. During our meeting, we were asked if it was possible to measure the quantity of virus captured within the Hemopurifier® during treatment? Our answer was yes, as our science team had measured this data point on three previous occasions. Normally, our focus is to measure viral load changes in patient blood to quantify the potential for benefit. In response to FDA's question, we modified our Medanta study protocol so that we could incorporate this secondary data point in a revised IDE submission to FDA. With this change in place, our protocol is now being administered to enrolled patients at the Medanta Medicity Institute. Our primary endpoint goal remains to demonstrate that our Hemopurifier® improves both immediate and rapid viral response rates when combined with interferon versus interferon alone. We remain convinced that our Hemopurifier® will offer an enduring opportunity to improve current and future iterations of HCV drug therapies. However, with the advent of the Aethlon ADAPT™ system, we have transitioned to being revenue stage organization whose value should no longer be attributed to one product application. On behalf of our dedicated team at Aethlon Medical, I thank you for your continued support.
Very truly yours,
James A. Joyce
Chairman, CEO
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the ability for the Company to derive business partnerships or future revenue streams using the Aethlon ADAPT™ system including the ability to introduce a targeted breast cancer therapy known as HER2osome™, there is no assurance that FDA will approve the initiation of the company�s clinical programs or provide market clearance of the company�s products, the ability to achieve the goals set out in the DARPA contract, future human studies of the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer therapies, the Hemopurifier�s® ability to capture exosomes and the impact it may have on disease conditions, the ability to successfully complete the Medanta HCV study and achieve positive results, the company�s ability to raise capital when needed, the Company�s ability to complete the development of its planned products, the Company�s ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company�s proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company�s Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jody Cain
Senior Vice President, Lippert/Heilshorn & Associates
310.691.7100
jcain@lhai.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com
AETHLON MEDICAL INC (OTC BB: AEMD) is a Showcase biotech, biodefense and defense stock on Investorideas.com
Visit the AETHLON MEDICAL INC (OTC BB: AEMD) showcase profile page
Disclosure/Disclaimer: AETHLON MEDICAL INC (OTC BB: AEMD) is a paid advertising client ($one thousand five hundred per month, $five thousand per month in 144 stock)